Literature DB >> 6662835

Synergy with double and triple antibiotic combinations compared.

M C Berenbaum, V L Yu, T P Felegie.   

Abstract

Combinations of two sets of antibiotics (gentamicin-carbenicillin-rifampicin and trimethoprim/sulphamethoxazole-carbenicillin-rifampicin) were tested against isolates of Pseudomonas maltophilia. An abbreviated checker-board method permitted tests with combinations of all three antibiotics and of each of the possible three pairs in each set. Triple combinations were usually synergistic, whereas 25% of combinations of pairs were antagonistic or additive. The modal degree of synergy was greater with combinations of three antibiotics than with combinations of any two. For any isolate, greater synergy was generally obtained with a triple than with a double combination, and the mean degree of synergy was always greater with triple than with double combinations. It was advantageous to add to double combinations even an antibiotic to which the organism was resistant. Organisms multiply resistant to three antibiotics were also resistant to 25% of combinations of pairs, but never resistant to combinations of all three. Synergy was more likely to be present at all antibiotic ratios with triple than with double combinations. Since ratios at the site of action may differ greatly from that of the administered combination, there would be substantial clinical benefit in identifying sets of antibiotics of which combinations at all ratios showed synergy. The search for these may entail exploring multicomponent combinations and, with conventional methods, this raises a considerable logistic problem. A strategy is therefore proposed, designed to find antibiotic sets showing synergy at all ratios.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662835     DOI: 10.1093/jac/12.6.555

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.

Authors:  S Vartivarian; E Anaissie; G Bodey; H Sprigg; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 2.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Accelerated evolution of resistance in multidrug environments.

Authors:  Matthew Hegreness; Noam Shoresh; Doris Damian; Daniel Hartl; Roy Kishony
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

4.  Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.

Authors:  Peter Ankomah; Bruce R Levin
Journal:  PLoS Pathog       Date:  2012-01-12       Impact factor: 6.823

Review 5.  When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  Clin Lab Med       Date:  2019-06-12       Impact factor: 1.935

6.  The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations.

Authors:  Peter Ankomah; Paul J T Johnson; Bruce R Levin
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

Review 7.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640

8.  Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro.

Authors:  Mohamed El-Azizi
Journal:  Int J Microbiol       Date:  2016-04-18

9.  Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generation.

Authors:  Colleen M Courtney; Samuel M Goodman; Toni A Nagy; Max Levy; Pallavi Bhusal; Nancy E Madinger; Corrella S Detweiler; Prashant Nagpal; Anushree Chatterjee
Journal:  Sci Adv       Date:  2017-10-04       Impact factor: 14.136

10.  Multiplexed deactivated CRISPR-Cas9 gene expression perturbations deter bacterial adaptation by inducing negative epistasis.

Authors:  Peter B Otoupal; William T Cordell; Vismaya Bachu; Madeleine J Sitton; Anushree Chatterjee
Journal:  Commun Biol       Date:  2018-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.